physostigmine has been researched along with Schizophrenia in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (79.41) | 18.7374 |
1990's | 1 (2.94) | 18.2507 |
2000's | 4 (11.76) | 29.6817 |
2010's | 1 (2.94) | 24.3611 |
2020's | 1 (2.94) | 2.80 |
Authors | Studies |
---|---|
Daaboul, A; Nuding, S; Schott, A; Sedding, D | 1 |
Barak, S; Weiner, I | 1 |
Davis, JM; Janowsky, DS | 1 |
Arai, M; Arikawa-Hirasawa, E; Arinami, T; Horiuchi, Y; Inada, T; Iritani, S; Ishiguro, H; Ishikawa, M; Itokawa, M; Kakita, A; Keino-Masu, K; Nawa, H; Niizato, K; Ozaki, N; Syu, A; Takahashi, H; Takahashi, M; Tanaka, S | 1 |
Aasen, I; Kumari, V; Reed, C; Sharma, T | 1 |
Kircher, T; Leucht, S; Thienel, R; Voss, B | 1 |
Luchins, DJ | 1 |
Coco, A; Davis, KL; Deutsch, SI; Horvath, T; Levy, MI; Mohs, RC; Rothpearl, AB; Stockton, D | 1 |
Berger, PA | 1 |
Edelstein, P; Garver, DL; Hirschowitz, J; Kanter, DR; Schultz, JR | 1 |
Davis, JM | 3 |
Barchas, JD; Berger, PA; Davis, KL; Hollister, LE | 1 |
Berger, PA; Davis, KL | 1 |
Luauté, JP; Thionville, M | 1 |
Boueilh, P; Bourgeois, M; Gauthier-Bernard, F; Peyre, C | 1 |
Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC | 1 |
Anderson, MH; Lynch, H | 1 |
Adler, LE; Freedman, R; Griffith, J; Hoffer, LJ; Waldo, MC | 1 |
Beckmann, H; Heinsen, H; Maurer, K; Riederer, P | 1 |
Davis, JM; el-Yousef, MK; Fann, WE; Janowsky, DS | 1 |
Fann, WE; Gerber, CJ; Lake, CR; McKenzie, GM | 1 |
Davis, JM; el-Yousef, MK; Janowsky, D; Sekerke, HJ | 1 |
Klawans, HL; Rubovits, R | 1 |
Davis, JM; Janowsky, D | 1 |
Hunger, J; Modestin, J; Schwartz, RB | 1 |
Davis, JM; el-Yousef, K; Janowsky, DS; Sekerke, HJ | 1 |
Barry, TJ; Rubin, LS | 1 |
Davis, JM; el-Yousef, MK; Janowsky, DS; Sekerke, HJ | 1 |
Ambani, LM; Bowers, MB; Van Woert, MH | 1 |
Davis, JM; el-Yosef, MK; Janowsky, DS; Sekerke, HJ | 1 |
Bilikiewicz, T; Galuszko, P | 1 |
Dovgal', GM; Slavutskaia, LIa | 1 |
2 review(s) available for physostigmine and Schizophrenia
Article | Year |
---|---|
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Biochemistry and the schizophrenia. Old concepts and new hypothesis.
Topics: Acetylcholine; Amphetamine; Animals; Brain; Cocaine; Dopamine; Endorphins; gamma-Aminobutyric Acid; Humans; Methylphenidate; Naloxone; Norepinephrine; Phenethylamines; Physostigmine; Schizophrenia; Schizophrenia, Paranoid | 1981 |
7 trial(s) available for physostigmine and Schizophrenia
Article | Year |
---|---|
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior | 2006 |
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Topics: Acetylcholine; Adult; Aged; Bipolar Disorder; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Physostigmine; Psychotic Disorders; Receptors, Cholinergic; Schizophrenia | 1978 |
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.
Topics: Adult; Arousal; Attention; Chewing Gum; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Nicotine; Physostigmine; Receptors, Muscarinic; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted | 1992 |
Central atropine-like toxicity in combined psychotropic drug administration.
Topics: Antiparkinson Agents; Antipsychotic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Parasympatholytics; Phenothiazines; Physostigmine; Placebos; Psychoses, Substance-Induced; Schizophrenia | 1972 |
Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.
Topics: Adolescent; Adult; Amnesia; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Anxiety; Benztropine; Female; Hallucinations; Humans; Injections, Intramuscular; Phenothiazines; Physostigmine; Placebos; Psychoses, Substance-Induced; Schizophrenia; Tropanes | 1973 |
[Investigation about an influence of physostigmine on schizophrenic symptoms (author's transl)].
Topics: Adult; Clinical Trials as Topic; Depression; Female; Humans; Male; Middle Aged; Neostigmine; Physostigmine; Psychiatric Status Rating Scales; Schizophrenia; Statistics as Topic | 1973 |
Parasympathetic suppression of manic symptoms by physostigmine.
Topics: Acetylcholine; Adult; Affect; Bipolar Disorder; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Injections, Intravenous; Male; Neostigmine; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Placebos; Remission, Spontaneous; Schizophrenia | 1973 |
25 other study(ies) available for physostigmine and Schizophrenia
Article | Year |
---|---|
Successful Treatment of an Acute High-Dose Clozapine Poisoning without Detoxication.
Topics: Adult; Antipsychotic Agents; Clozapine; Gastric Lavage; Humans; Male; Physostigmine; Schizophrenia | 2021 |
Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Attention; Cholinergic Antagonists; Clozapine; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Glycine; Haloperidol; Inhibition, Psychological; Male; Physostigmine; Rats; Rats, Wistar; Schizophrenia; Scopolamine | 2009 |
Antipsychotic properties of muscarinic drugs.
Topics: Animals; Antipsychotic Agents; Cholinergic Agents; Cholinesterase Inhibitors; Humans; Isoflurophate; Physostigmine; Psychoses, Substance-Induced; Pyridines; Rats; Schizophrenia; Thiadiazoles | 2009 |
Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; Female; Genetic Association Studies; Haloperidol; Heparan Sulfate Proteoglycans; Humans; Japan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Physostigmine; Polymorphism, Single Nucleotide; Prefrontal Cortex; Reserpine; Schizophrenia | 2010 |
Developments in biological psychiatry: clinical applications to the major psychoses.
Topics: Amphetamine; Antidepressive Agents; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Humans; Hydrocortisone; Lithium; Neurotransmitter Agents; Physostigmine; Psychotic Disorders; Research; Schizophrenia; Tomography, X-Ray Computed | 1982 |
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Topics: Acetylcholinesterase; Adult; Aged; Alzheimer Disease; Cerebrospinal Fluid Proteins; Cholinesterase Inhibitors; Depressive Disorder; Dyskinesia, Drug-Induced; Humans; Middle Aged; Physostigmine; Schizophrenia | 1983 |
Physostigmine and lithium response in the schizophrenias.
Topics: Adult; Double-Blind Method; Female; Humans; Infusions, Parenteral; Lithium; Male; Physostigmine; Premedication; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1981 |
Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Child; Cognition Disorders; Dopamine; Emotions; Humans; Methylphenidate; Middle Aged; Monoamine Oxidase; Neostigmine; Norepinephrine; Parasympathetic Nervous System; Phenothiazines; Physostigmine; Schizophrenia; Sympathetic Nervous System | 1975 |
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
Topics: Biogenic Amines; Bipolar Disorder; Humans; Huntington Disease; Movement Disorders; Parasympathetic Nervous System; Physostigmine; Psychotic Disorders; Research Design; Schizophrenia; Tranquilizing Agents | 1975 |
[Anti-cholinergic confusional states connected with chemotherapy of mental diseases: value of eserine sulfate (physostigime)].
Topics: Cognition Disorders; Confusion; Depression; Humans; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia | 1978 |
[Neuroleptic tardive dyskinesias. Completion of the inquiry regarding 1,480 psychiatric hospital patients].
Topics: Age Factors; Aged; Child; Choline; Dyskinesia, Drug-Induced; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Physostigmine; Schizophrenia; Tranquilizing Agents | 1977 |
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia | 1977 |
Atropine coma therapy in psychiatry: clinical observations over a 20-year period and a review of the literature.
Topics: Adolescent; Adult; Aged; Antidotes; Anxiety; Atropine; Bipolar Disorder; Coma; Electronarcosis; Humans; Indiana; Middle Aged; Neurotic Disorders; Physostigmine; Psychiatric Nursing; Psychotherapy; Psychotic Disorders; Retrospective Studies; Schizophrenia | 1975 |
Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychoses and to pharmacological conditions.
Topics: Adult; Aged; Alzheimer Disease; Arousal; Attention; Biperiden; Electroencephalography; Evoked Potentials, Auditory; Humans; Limbic System; Physostigmine; Piperidines; Reaction Time; Schizophrenia; Signal Processing, Computer-Assisted | 1989 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dihydroergotoxine; Drug Interactions; Electroconvulsive Therapy; Gonadal Steroid Hormones; Guanethidine; Haloperidol; Humans; Lithium; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia; Thiothixene; Thioxanthenes; Vitamins | 1974 |
Cholinergic suppression of tardive dyskinesia.
Topics: Acetylcholine; Aged; Binding Sites; Brain; Dopamine; Female; Humans; Hyperkinesis; Injections, Intravenous; Male; Middle Aged; Movement Disorders; Physostigmine; Schizophrenia; Synaptic Transmission; Time Factors; Tranquilizing Agents | 1974 |
Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
Topics: Adult; Aged; Anxiety Disorders; Edrophonium; Female; Humans; Male; Middle Aged; Movement Disorders; Neurocognitive Disorders; Physostigmine; Schizophrenia; Scopolamine; Tranquilizing Agents | 1974 |
Proceedings: Cholinergic and adrenergic balance in mania and schizophrenia.
Topics: Bipolar Disorder; Humans; Parasympathetic Nervous System; Physostigmine; Schizophrenia; Sympathetic Nervous System | 1974 |
A two factor theory of schizophrenia.
Topics: Acetylcholine; Amphetamine; Animals; Bipolar Disorder; Brain; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Humans; Methyl Ethers; Methylphenidate; Physostigmine; Schizophrenia; Stereoisomerism; Stereotyped Behavior | 1974 |
The effects of conjunctival instillation of eserine and homatropine on pupillary reactivity in schizophrenics.
Topics: Adaptation, Ocular; Adult; Conjunctiva; Darkness; Humans; Light; Male; Ophthalmic Solutions; Parasympathetic Nervous System; Photic Stimulation; Physostigmine; Pupil; Reflex; Reflex, Pupillary; Schizophrenia; Tropanes | 1973 |
Antagonistic effects of physostigmine and methylphenidate in man.
Topics: Affective Symptoms; Behavior; Bipolar Disorder; Humans; Inhibition, Psychological; Methylphenidate; Neostigmine; Physostigmine; Schizophrenia; Scopolamine | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; Handwriting; Humans; Male; Mental Disorders; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Physostigmine; Salicylates; Schizophrenia; Substance-Related Disorders; Time Factors; Trifluoperazine; Tropanes | 1973 |
Reversal of benztropine toxicity by physostigmine.
Topics: Brain; Chlorpromazine; Female; Humans; Imipramine; Memory, Short-Term; Parasympatholytics; Perphenazine; Physostigmine; Schizophrenia; Thioridazine | 1972 |
[Atropine coma and its therapeutic value].
Topics: Atropine; Chronic Disease; Coma; Humans; Mental Disorders; Neurotic Disorders; Physostigmine; Psychotic Disorders; Schizophrenia | 1970 |
[Atropine coma in chronic schizophrenia].
Topics: Adult; Atropine; Chronic Disease; Coma; Convulsive Therapy; Female; Humans; Hypertension; Male; Methods; Middle Aged; Physostigmine; Schizophrenia; Vomiting | 1969 |